z-logo
open-access-imgOpen Access
1- and 2-Adrenergic Receptor Gene Variation, -Blocker Use and Risk of Myocardial Infarction and Stroke
Author(s) -
Rozenn N. Lemaître,
Susan R. Heckbert,
N Sotoodehnia,
Josh Bis,
Nicholas L. Smith,
Kristin D. Marciante,
Lucia A. Hindorff,
Leslie A. Lange,
Thomas S. Lumley,
Kenneth Rice,
Kerri L. Wiggins,
B. M. Psaty
Publication year - 2008
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2007.71
Subject(s) - medicine , odds ratio , stroke (engine) , myocardial infarction , cardiology , confidence interval , mechanical engineering , engineering
The benefits of beta-blocker therapy may depend on underlying genetic susceptibility.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom